| Date Filed | Type | Description |
| 09/27/2023 |
4
| Datin James A (Director) has filed a Form 4 on ORASURE TECHNOLOGIES INC|
Txns:
| Granted 3,922 shares
@ $5.71, valued at
$22.4k
Paid exercise price by delivering 1,062 shares
@ $5.71, valued at
$6.1k
|
|
| 08/17/2023 |
4
| Anthony Michele Marie (SVP Finance & CAO) has filed a Form 4 on ORASURE TECHNOLOGIES INC|
Txns:
| Sold 1,758 shares
@ $6.5, valued at
$11.4k
Exercised 1,758 options to buy
@ $5.71, valued at
$10k
|
|
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/10/2023 |
4
| McGrath Kenneth J (CFO) has filed a Form 4 on ORASURE TECHNOLOGIES INC|
Txns:
| Paid exercise price by delivering 12,524 shares
@ $6.49, valued at
$81.3k
|
|
| 08/04/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/04/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/03/2023 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits I... |
| 08/02/2023 |
8-K/A
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/20/2023 |
8-K
| Quarterly results |
| 06/30/2023 |
4
| Datin James A (Director) has filed a Form 4 on ORASURE TECHNOLOGIES INC|
Txns:
| Granted 4,004 shares
@ $4.995, valued at
$20k
Paid exercise price by delivering 1,084 shares
@ $4.995, valued at
$5.4k
|
|
| 06/06/2023 |
4
| EGLINTON MANNER CARRIE (President & CEO) has filed a Form 4 on ORASURE TECHNOLOGIES INC|
Txns:
| Paid exercise price by delivering 47,211 shares
@ $5.48, valued at
$258.7k
|
|
| 05/31/2023 |
4
| McGrath Kenneth J (CFO) has filed a Form 4 on ORASURE TECHNOLOGIES INC|
Txns:
| Bought 100,000 shares
@ $4.9281, valued at
$492.8k
|
|
| 05/17/2023 |
4
| Aspinall Mara G. (Director) has filed a Form 4 on ORASURE TECHNOLOGIES INC|
Txns:
| Paid exercise price by delivering 5,400 shares
@ $5.615, valued at
$30.3k
Granted 24,517 shares
@ $0 |
|
| 05/17/2023 |
4
| Datin James A (Director) has filed a Form 4 on ORASURE TECHNOLOGIES INC|
Txns:
| Paid exercise price by delivering 5,418 shares
@ $5.615, valued at
$30.4k
Granted 19,802 shares
@ $0 |
|
| 05/17/2023 |
4
| Marmora Lelio (Director) has filed a Form 4 on ORASURE TECHNOLOGIES INC|
Txns:
| Paid exercise price by delivering 6,000 shares
@ $5.615, valued at
$33.7k
Granted 19,802 shares
@ $0 |
|
| 05/17/2023 |
4
| Shulkin David (Director) has filed a Form 4 on ORASURE TECHNOLOGIES INC|
Txns:
| Paid exercise price by delivering 5,014 shares
@ $5.615, valued at
$28.2k
Granted 19,802 shares
@ $0 |
|
| 05/17/2023 |
4
| Whitaker Anne Clem (Director) has filed a Form 4 on ORASURE TECHNOLOGIES INC|
Txns:
| Paid exercise price by delivering 4,400 shares
@ $5.615, valued at
$24.7k
Paid exercise price by delivering 2,323 shares
@ $5.3025, valued at
$12.3k
|
|
| 05/17/2023 |
4
| Gagliano Nancy J (Director) has filed a Form 4 on ORASURE TECHNOLOGIES INC|
Txns:
| Granted 19,802 shares
@ $0 |
|
| 05/16/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"ORASURE TECHNOLOGIES, INC. STOCK AWARD PLAN ARTICLE 1 ESTABLISHMENT AND PURPOSE Establishment. Epitope, Inc. established this Plan as the Epitope, Inc. 2000 Stock Award Plan, effective as of February 15, 2000, and the Plan was approved by shareholders of Epitope, Inc. at the 2000 annual shareholders meeting. Effective September 29, 2000, in connection with the merger of Epitope, Inc. with and into OraSure Technologies, Inc., the name of the Plan was changed to the OraSure Technologies, Inc. 2000 Stock Award Plan and the Plan was adopted as a stock award plan of OraSure Technologies, Inc. The Plan was amended and restated, subject to shareholder approval, effective May 16, 2006. The Plan was amended further, subject to shareholder approval, effective May 13, 2008. The Plan again was amended..." |
|
| 05/12/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits ... |
| 05/10/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/10/2023 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits I... |
| 04/27/2023 |
PX14A6G
| Form PX14A6G - Notice of exempt solicitation submitted by non-management: |
| 04/14/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/14/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/14/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/06/2023 |
4
| Datin James A (Director) has filed a Form 4 on ORASURE TECHNOLOGIES INC|
Txns:
| Granted 3,090 shares
@ $6.4725, valued at
$20k
Paid exercise price by delivering 837 shares
@ $6.4725, valued at
$5.4k
|
|
| 03/27/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/27/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/16/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/14/2023 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits ... |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 7.1% stake in OraSure Technologies Inc. |
|